Acumen Pharmaceuticals Inc (ABOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Operating Expenses | 9,206 | 8,415 | 3,935 | 3,441 | 3,793 |
| Operating Income | -9,206 | -8,415 | -3,935 | -3,441 | -3,793 |
| Other Income | 75 | 66 | 33 | -57,917 | -23,204 |
| Pre-tax Income | -9,131 | -8,349 | -3,902 | -61,358 | -26,997 |
| Net Income Continuous | -9,131 | -8,349 | -3,902 | -61,358 | -26,997 |
| Net Income | $-9,129 | $-8,349 | $-3,902 | $-61,358 | $-26,997 |
| EPS Basic Total Ops | -0.23 | 201.42 | -0.10 | -141.93 | -64.41 |
| EPS Basic Continuous Ops | -0.23 | 201.53 | -0.10 | -142.03 | -64.41 |
| EPS Diluted Total Ops | -0.23 | 201.42 | -0.10 | -141.93 | -64.41 |
| EPS Diluted Continuous Ops | -0.23 | 201.53 | -0.10 | -142.03 | -64.41 |
| EBITDA(a) | $-8,953 | $-8,251 | $-3,935 | $-3,441 | $-3,793 |